Table 1.
CTLA-4 inhibitor | PD-1/PD-L1 inhibitor | ||
---|---|---|---|
Pituitary | Hypophysitis/hypopituitarism | +++ | – |
Isolated ACTH deficiency | + | ++ | |
Thyroid | Thyroiditis/transient hyperthyroidism | ++ | +++ |
Hypothyroidism | ++ | +++ | |
Graves’ disease/thyroid eye disease | + | ? | |
Pancreas | Insulin-deficient diabetes | – | ++ |
Adrenal | Primary adrenal insufficiency | + | + |
ACTH: adrenocorticotropic hormone; CTLA-4: cytotoxic T-cell lymphocyte antigen-4; PD-1/PD-L1: program death-1 receptor or ligand.
>5%.
0.5–5%.
<0.5%.
Unknown.
Not described.